[HTML][HTML] Neutralizing antibodies for the prevention and treatment of COVID-19

L Du, Y Yang, X Zhang - Cellular & molecular immunology, 2021 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …

Neutralizing antibodies for the prevention and treatment of COVID-19.

L Du, Y Yang, X Zhang - Cellular & Molecular Immunology, 2021 - europepmc.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …

Neutralizing antibodies for the prevention and treatment of COVID-19

D Lanying, Y Yang, X Zhang - Cellular & Molecular …, 2021 - search.proquest.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …

Neutralizing antibodies for the prevention and treatment of COVID-19

L Du, Y Yang, X Zhang - Cellular & molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …

[HTML][HTML] Neutralizing antibodies for the prevention and treatment of COVID-19

L Du, Y Yang, X Zhang - Cellular and Molecular Immunology, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …

Neutralizing antibodies for the prevention and treatment of COVID-19

L Du, Y Yang, X Zhang - Cellular & Molecular Immunology, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) initiates the infection process by binding to the viral cellular …